ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00542724
Recruitment Status : Completed
First Posted : October 11, 2007
Last Update Posted : August 3, 2015
Sponsor:
Information provided by (Responsible Party):
Biodel

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2008
  Study Completion Date : No date given
  Certification/Extension First Submitted : January 21, 2010